| P50 | author | Wolfgang J Streit | Q88588846 |
| P2093 | author name string | Habibeh Khoshbouei | |
| | Ingo Bechmann | |
| | Heiko Braak | |
| | Kelly Del Tredici | |
| | Wolf Müller | |
| | Christian Eisenlöffel | |
| | Judith Leyh | |
| | Julia Lier | |
| P2860 | cites work | Mild cognitive impairment: pathology and mechanisms. | Q24631255 |
| | Microglial pathology | Q26992285 |
| | Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology | Q27327835 |
| | Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo | Q27860578 |
| | Neuropathological stageing of Alzheimer-related changes | Q27860862 |
| | The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 |
| | The preclinical phase of the pathological process underlying sporadic Alzheimer's disease | Q28083428 |
| | Neuroinflammation in Alzheimer's disease | Q28259238 |
| | Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer’s disease | Q30141537 |
| | TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice | Q33343490 |
| | Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes | Q33772805 |
| | Proliferation in the Alzheimer hippocampus is due to microglia, not astroglia, and occurs at sites of amyloid deposition | Q34146055 |
| | Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function | Q34172143 |
| | Primary age-related tauopathy (PART): a common pathology associated with human aging | Q34445021 |
| | Are cases with tau pathology occurring in the absence of Aβ deposits part of the AD-related pathological process? | Q34445601 |
| | PART is part of Alzheimer disease | Q34460027 |
| | Inflammation, autotoxicity and Alzheimer disease | Q34469472 |
| | Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry | Q34556945 |
| | Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide | Q34963822 |
| | The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease | Q34992780 |
| | Neuroinflammation in Alzheimer's disease wanes with age | Q35640906 |
| | National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach | Q35706615 |
| | The microglial phagocytic role with specific plaque types in the Alzheimer disease brain | Q35789675 |
| | Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study | Q36164195 |
| | Microglial malfunction: the third rail in the development of Alzheimer's disease | Q36348184 |
| | Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology. | Q36356347 |
| | Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease | Q36893432 |
| | Relation of neuropathology with cognitive decline among older persons without dementia | Q37155465 |
| | Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease | Q37331433 |
| | Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease | Q37332710 |
| | Microglia actions in Alzheimer’s disease. | Q38162232 |
| | Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective | Q38516632 |
| | Microglia in dementia with Lewy bodies | Q40374193 |
| | Cerebral amyloid angiopathy and granulomatous angiitis: immunohistochemical study using antibodies to the Alzheimer A4 peptide | Q41212490 |
| | Presence of severe neuroinflammation does not intensify neurofibrillary degeneration in human brain | Q42239439 |
| | Frequency of stages of Alzheimer-related lesions in different age categories | Q42445469 |
| | Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease | Q45305307 |
| | beta-Amyloid peptides induce degeneration of cultured rat microglia | Q46885770 |
| | Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease | Q48007049 |
| | Dystrophic microglia in the aging human brain | Q48090856 |
| | Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis | Q48100149 |
| | Progressive telomere shortening occurs in cultured rat microglia, but not astrocytes | Q48129206 |
| | Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. | Q48219387 |
| | Evidence that aging and amyloid promote microglial cell senescence | Q48232021 |
| | Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease. | Q48421283 |
| | Neuroinflammation: no rose by any other name | Q48474962 |
| | Phases of A beta-deposition in the human brain and its relevance for the development of AD. | Q48567985 |
| | Giant cell arteritis in association with cerebral amyloid angiopathy: immunohistochemical and molecular studies. | Q48577484 |
| | Microglial activation in early stages of amyloid beta protein deposition | Q48612917 |
| | Inhomogeneous distribution of Iba-1 characterizes microglial pathology in Alzheimer's disease | Q48627278 |
| | Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years | Q48835886 |
| | Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor | Q48933977 |
| | Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies. | Q51129033 |
| | "Preclinical" AD revisited: neuropathology of cognitively normal older adults. | Q51975129 |
| | Increased senile plaques without microglia in Alzheimer's disease. | Q53184055 |
| | Activation of microglial cells by beta-amyloid protein and interferon-gamma. | Q53202007 |
| | Role of microglia in senile plaque formation. | Q53210237 |
| | A lysosomal marker for activated microglial cells involved in Alzheimer classic senile plaques. | Q53210696 |
| | Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells. | Q53220157 |
| | Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity. | Q53392859 |
| | Microglia in Alzheimer's Disease: Activated, Dysfunctional or Degenerative. | Q55073016 |
| | Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ | Q61709806 |
| | Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease | Q67960261 |
| | The pathological process underlying Alzheimer's disease in individuals under thirty | Q82953907 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| | Human Subjects | Q21535022 |
| | microglia | Q1622829 |
| P304 | page(s) | 2550-2562 | |
| P577 | publication date | 2018-11-11 | |
| P1433 | published in | Glia | Q15716658 |
| P1476 | title | Microglial activation occurs late during preclinical Alzheimer's disease | |
| P478 | volume | 66 | |